Type 2 Diabetes: What’s new in the RACGP guidelines?

About Type 2 Diabetes: What’s new in the RACGP guidelines?

The updated Royal Australian College of General Practitioners (RACGP) guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence. Across six webinars, contributors to the guidelines, Dr Gary Deed (GP), and Michelle Robins (nurse practitioner and credentialled diabetes educator) are joined by Dr Tom Dover (endocrinologist) to discuss key updates as they share their unique insights and practical guidance on the management of type 2 diabetes. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. Sanofi‐Aventis Australia Pty Ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101753 Date of preparation August 2021

Publisher

RACGP

Category

education · health & fitness

Language

en

Explicit

No

First episode

22 Aug 2021

Latest episode

22 Aug 2021

Latest episodes

6 episodes in the feed.

1. 

   22 Aug 2021

   Mastering the Management of Type 2 Diabetes: Part 2

   A continuation of the previous episode, Dr Gary Deed (GP) and Dr Tom Dover (endocrinologist) continue to review the ADS type 2 diabetes treatment algorithm, with an in-depth discussion pharmacotherapy from initial therapies to considerations when selecting second-line agents and when to consider commencing insulin. Michelle Robins shares her tips and considerations on how to overcome inertia to starting insulin. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.

2. 

   22 Aug 2021

   What’s New in the 2020 RACGP Guidelines: Special Populations

   Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) discuss the key recommendations relating to some specific patient populations with type 2 diabetes, including early-onset type 2 diabetes, mental health, and the management of type 2 diabetes in older people and in aged-care facilities. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.

3. 

   22 Aug 2021

   Refreshing Key Concepts in Type 2 Diabetes

   Contributors to the RACGP guidelines, Dr Gary Deed (GP) and Michelle Robins (credentialled diabetes educator and nurse practitioner) along with endocrinologist Dr Tom Dover summarise why the updated guidelines were needed. Together, they consider the goals of therapy, what is meant by ‘patient-centred care’ and how it can be applied in routine clinical practice. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.

4. 

   22 Aug 2021

   An Update on Microvascular Complications

   Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) discuss microvascular complications including all forms of diabetic-related retinopathy, nephropathy and share their perspectives on medications, diabetic foot risk stratification, examination, and referrals. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.

5. 

   22 Aug 2021

   An Update on Diabetes and CVD

   Cardiovascular disease (CVD) is the leading cause of death in people with diabetes, making assessment, prevention and management of CVD risk a vital part of diabetes care.1 Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) consider the different risk assessment tools available, interventions to manage CVD risk and practical tips on approaching the multi-morbidity nature of type 2 diabetes and the application of patient-centred care. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References:  1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. 2. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J. and Broedl, U.C., 2015. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), pp.2117-2128.

6. 

   22 Aug 2021

   Mastering the Management of Type 2 Diabetes: Part 1

   Dr Gary Deed (GP) and Dr Tom Dover (endocrinologist) discuss the Australian type 2 diabetes management algorithm developed by the Australian Diabetes Society (ADS), dietary interventions such as high-protein and very low energy diets and pharmacotherapy considerations. Michelle Robins (CDE and nurse practitioner) highlights key educational points for people commencing on certain glucose-lowering agents. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. 2. Martínez-González, M.A., Salas-Salvadó, J., Estruch, R., Corella, D., Fitó, M., Ros, E. and Predimed Investigators, 2015. Benefits of the Mediterranean diet: insights from the PREDIMED study. Progress in cardiovascular diseases, 58(1), pp.50-60.

Contact Type 2 Diabetes: What’s new in the RACGP guidelines?

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.